GLOBOCAN 2022
COSTA RICA
Number of new cases Number of deaths Number of prevalent cases
(5-year)
13 325 6 072 38 750
Statistics at a glance, 2022
Males Females Both sexes
Population 2 587 802 2 594 550 5 182 352
Incidence* Costa Rica
Number of new cancer cases 6 808 6 517 13 325
Age-standardized incidence rate 185.5 173.5 177.7
Risk of developing cancer before the age 18.6 17.1 17.8
of 75 years (cum. risk %)
Top 3 leading cancers (ranked by Prostate Breast Prostate
cases)**
Stomach Thyroid Breast
Colorectum Colorectum Stomach
Mortality*
Number of cancer deaths 3 246 2 826 6 072
Age-standardized mortality rate 84.9 67.6 75.3
Risk of dying from cancer before the age 8.3 6.7 7.5
of 75 years (cum. risk %)
Top 3 leading cancers (ranked by Prostate Breast Stomach
deaths)**
Stomach Colorectum Colorectum
Colorectum Stomach Prostate
Prevalence* Kilometers
0 250 500 1000
5-year prevalent cases 18 731 20 019 38 750
Top 5 most frequent cancers**
Males Females Both sexes
Prostate
Breast
Prostate
Breast
Others Others
Thyroid Others
Stomach
Stomach
Colorectum Colorectum
Colorectum
Corpus uteri Thyroid
NHL Lung Stomach
Total: 6 808 Total: 6 517 Total: 13 325
Rank Cancer site Number of cases Percent Rank Cancer site Number of cases Percent Rank Cancer site Number of cases Percent
1st Prostate 1 796 26.4% 1st Breast 1 344 20.6% 1st Prostate 1 796 13.5%
2nd Stomach 759 11.1% 2nd Thyroid 752 11.5% 2nd Breast 1 344 10.1%
3rd Colorectum 495 7.3% 3rd Colorectum 626 9.6% 3rd Stomach 1 137 8.5%
4th Lung 360 5.3% 4th Corpus uteri 385 5.9% 4th Colorectum 1 121 8.4%
5th NHL 250 3.7% 5th Stomach 378 5.8% 5th Thyroid 877 6.6%
- Others 3 148 46.2% - Others 3 032 46.5% - Others 7 050 52.9%
Number of new cases in 2022, males, all ages Number of new cases in 2022, females, all ages Number of new cases in 2022, both sexes, all ages
The Global Cancer Observatory | All rights reserved | Globocan 2022 - 08.02.2024 Page 1
Incidence, Mortality and Prevalence by cancer site
New cases Deaths 5-year prevalence
Cancer Number Rank (%) Cum.risk Number Rank (%) Cum.risk Number Prop. (per 100 000)
Prostate 1 796 1 13.5 5.1 487 3 8.0 0.79 6 302 16.3
Breast 1 344 2 10.1 4.2 423 4 7.0 1.2 5 221 13.5
Stomach 1 137 3 8.5 1.6 774 1 12.7 0.99 1 548 4.0
Colorectum 1 121 4 8.4 1.6 709 2 11.7 0.89 3 288 8.5
Thyroid 877 5 6.6 1.4 38 22 0.63 0.04 3 245 8.4
Lung 527 6 4.0 0.84 400 6 6.6 0.55 669 1.7
Liver 425 7 3.2 0.56 420 5 6.9 0.57 461 1.2
NHL 411 8 3.1 0.64 226 9 3.7 0.30 1 303 3.4
Corpus uteri 385 9 2.9 1.3 88 16 1.4 0.26 1 461 3.8
Leukaemia 372 10 2.8 0.53 258 8 4.2 0.33 1 151 3.0
Pancreas 349 11 2.6 0.46 337 7 5.6 0.43 292 0.75
Cervix uteri 341 12 2.6 0.97 167 11 2.8 0.46 1 232 3.2
Bladder 280 13 2.1 0.38 121 12 2.0 0.11 846 2.2
Brain CNS 225 14 1.7 0.36 188 10 3.1 0.29 895 2.3
Kidney 193 15 1.4 0.32 105 14 1.7 0.15 607 1.6
Ovary 150 16 1.1 0.46 96 15 1.6 0.29 461 1.2
Melanoma 134 17 1.0 0.19 59 18 0.97 0.07 465 1.2
Multiple myeloma 125 18 0.94 0.20 114 13 1.9 0.17 360 0.93
Testis 114 19 0.86 0.29 19 25 0.31 0.05 469 1.2
Lip, oral cavity 107 20 0.80 0.16 42 21 0.69 0.06 321 0.83
Hodgkin lymphoma 106 21 0.80 0.16 44 20 0.73 0.05 381 0.98
Larynx 82 22 0.62 0.13 46 19 0.76 0.06 254 0.66
Oesophagus 71 23 0.53 0.09 65 17 1.1 0.08 81 0.21
Gallbladder 59 24 0.44 0.08 33 23 0.54 0.05 71 0.18
Penis 41 25 0.31 0.13 11 28 0.18 0.02 133 0.34
Salivary glands 39 26 0.29 0.05 15 26 0.25 0.02 120 0.31
Oropharynx 36 27 0.27 0.06 26 24 0.43 0.04 97 0.25
Vulva 30 28 0.23 0.08 12 27 0.20 0.02 86 0.22
Hypopharynx 22 29 0.17 0.02 6 30 0.10 0.01 30 0.08
Kaposi sarcoma 18 30 0.14 0.02 6 30 0.10 0.01 39 0.10
Nasopharynx 15 31 0.11 0.03 7 29 0.12 0.01 52 0.13
Vagina 10 32 0.08 0.03 3 32 0.05 0.00 26 0.07
All cancers 13 325 - - 17.8 6 072 - - 7.5 38 750 -
All cancers excl. NMSC 11 817 - - 16.1 5 994 - - 7.4 33 693 -
Data source and methods
Incidence Incidence Mortality Males Females
Country-specific data source: National cancer registry Prostate 45.6 11.1 Prostate 45.6
Method: National (or sub-national with coverage greater than Breast 37.5 10.6 Breast 37.5
50%) rates projected to 2022
Colorectum 14.3 8.6 Stomach 19.6 9.1
Mortality
Stomach 14.0 9.5 Colorectum 13.2 15.4
Thyroid 13.8 0.5 Corpus uteri 10.7
Country-specific data source: National (WHO) Corpus uteri 10.7 2.1 Cervix uteri 10.6
Method: National rates projected to 2022 Cervix uteri 10.6 4.6 Lung 9.7 4.1
Lung 6.8 4.9 NHL 7.5 4.0
Prevalence Leukaemia 6.1 3.7 Leukaemia 6.9 5.5
NHL 5.7 2.9 Liver 6.3 4.0
Computed using sex-; site- and age-specific incidence to 1-;3-
and 5-year prevalence ratios from Nordic countries for the period Liver 5.0 5.1 Bladder 5.4 1.5
(2011-2020), and scaled using Human Development Index (HDI)
Ovary 4.3 2.5 Pancreas 4.5 3.9
ratios.
Pancreas 4.2 4.0 Brain CNS 4.5 3.0
Testis 4.0 0.6 Ovary 4.3
Brain CNS 3.7 2.8 Testis 4.0
70 60 50 40 30 20 10 0 10 20 30 40 50 60 70 70 60 50 40 30 20 10 0 10 20 30 40 50 60 70
ASR (World) incidence and mortality rates, top 15 cancers** ASR (World) incidence rates per sex, top 15 cancers**
Page 2
* includes non-melanoma skin cancer (NMSC)
** NMSC included in other cancers
Age standardization using world population (see link)
References
Cancer incidence and mortality data
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020:
Website citation GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.
2021 Feb 4. doi: 10.3322/caac.21660. Epub ahead of print. PMID: 33538338.
Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).
Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020:
from: https://gco.iarc.who.int/today, accessed [DD Month YYYY].
An overview. Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.
© IARC 1965-2024 | All Rights Reserved | https://gco.iarc.who.int | https://gco.iarc.who.int/today
